Nick Sudbury takes a look at the impact of missed dividend payments and assesses which funds and trusts might perform better than others.
Funds and Investment Trusts
The specialist healthcare and biotech investment trusts have been one of the best performing areas of the market during the pandemic and have delivered excellent long-term returns.
How you plan for and react to extreme events like the recent sell-off will go a long way towards determining the sort of long-term returns you are going to make, writes Nick Sudbury.
Infrastructure is a defensive type of holding that is well-placed to protect its dividends, writes Nick Sudbury.
It is too early to be overly confident, but we are gradually building confidence in the outlook for the market, writes Jamie Ross of Henderson EuroTrust.
The flight to safety has sent high-yield bond prices plummeting, but the market may well have over reacted.
Ben Lofthouse, Head of Global Equity Income, and Jane Shoemake, Investment Director, assess the outlook for global dividends in the wake of the COVID-19 pandemic.
Laura Foll, Co-Fund Manager for Lowland Investment Company, delivers an outlook on the state of UK dividends in consideration of COVID-19.
TR European Growth Trust Manager Ollie Beckett talks about how he is positioning the trust’s portfolio for the economic recovery from COVID-19.
A whole raft of UK companies have announced dividend cuts in the last few weeks and this will have a knock on effect on the income paid out by the funds that invest in them.